CKD Bio Corp. (KRX: 063160)
South Korea flag South Korea · Delayed Price · Currency is KRW
22,000
+200 (0.92%)
Nov 15, 2024, 3:30 PM KST

CKD Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2017 - 2013
Period Ending
Nov '24 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2017 - 2013
Market Capitalization
120,965130,566229,313438,328158,885106,437
Upgrade
Market Cap Growth
6.51%-43.06%-47.68%175.88%49.28%68.02%
Upgrade
Enterprise Value
267,745251,285333,496515,471171,618114,125
Upgrade
Last Close Price
22050.0023800.0041800.0079707.0029348.9919529.89
Upgrade
PE Ratio
---69.4712.8913.22
Upgrade
PS Ratio
0.760.841.613.521.160.85
Upgrade
PB Ratio
0.920.881.422.601.000.72
Upgrade
P/TBV Ratio
1.000.911.442.641.010.73
Upgrade
P/OCF Ratio
---90.869.356.85
Upgrade
EV/Sales Ratio
1.671.612.344.141.250.92
Upgrade
EV/EBITDA Ratio
-80.3460.0725.986.817.15
Upgrade
EV/EBIT Ratio
---67.7611.1316.28
Upgrade
EV/FCF Ratio
-11.73-----
Upgrade
Debt / Equity Ratio
1.210.940.680.470.180.03
Upgrade
Debt / EBITDA Ratio
-44.4119.704.021.130.31
Upgrade
Asset Turnover
0.510.510.490.480.66-
Upgrade
Inventory Turnover
2.041.871.992.143.38-
Upgrade
Quick Ratio
0.650.490.750.581.062.02
Upgrade
Current Ratio
1.561.512.351.921.783.31
Upgrade
Return on Equity (ROE)
-16.26%-10.80%-3.98%3.79%8.01%-
Upgrade
Return on Assets (ROA)
-4.96%-3.03%-2.46%1.84%4.61%-
Upgrade
Return on Capital (ROIC)
-5.54%-3.32%-2.75%2.18%5.68%-
Upgrade
Earnings Yield
-19.12%-12.79%-2.87%1.42%7.72%7.48%
Upgrade
FCF Yield
-18.87%-7.20%-11.50%-12.97%-19.09%-0.81%
Upgrade
Dividend Yield
0.00%-0.24%0.25%0.65%0.98%
Upgrade
Payout Ratio
0.00%--16.53%8.36%25.79%
Upgrade
Buyback Yield / Dilution
0.02%--1.40%-0.45%0.00%0.03%
Upgrade
Total Shareholder Return
0.02%--1.16%-0.20%0.65%1.01%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.